RILUZOLE | RILUZOLE | ATC N07XX02
NERVOUS SYSTEM NEUROPROTECTIVE INHIBITORY EFFECT ON GLUTAMATE RELEASE PARTIAL INACTIVATION OF VOLTAGE-DEPENDENT SODIUM CHANNELS (PMID25548669) SEDATIVES MYORELAXANT TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) ACTIVATES SK CHANNELS BUT NOT BK CHANNELS | ORAL | Cmax 739 NANOMOLAR F 60 PERCENT VD 245 LITER PPB 96 PERCENT HT 12 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER | SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (SK) CHANNELS (PMID26311432) PDB 5V02 (A POSITIVE ALLOSTERIC MODULATOR BINDING POCKET IN SK2 ION CHANNELS IS SHARED BY RILUZOLE AND CYPPA) LIGAND CODE = 657 (link to the list of PDB complexes) Download experimental 3D coordinates of 657 with added hydrogens | Sodium channel protein type 5 subunit alpha UNIPROT Q14524 SCN5A more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |